Search

Cookies

We use cookies to improve your experience. By continuing, you accept our use of cookies.

Business

TCS Share Price Targets: Analysts Divided Post-Q2 Results, Targets Span Rs 1,578 to Rs 3,266

· · 3 min read

Tata Consultancy Services (TCS) received mixed analyst ratings following its Q2 results, with price targets ranging widely from Nirmal Bang's Rs 1,578 to Centrum Broking's Rs 3,266. Brokerages expressed concerns over underlying growth and margin pressures.

Tata Consultancy Services (TCS) has garnered diverse opinions from financial analysts after its recent September quarter results, with share price targets showcasing a significant spread. While some brokerages maintained a positive outlook, others expressed reservations regarding the IT giant's performance and near-term prospects.

Wide Range in Analyst Targets

The highest share price target for TCS currently stands at Rs 3,266, set by Centrum Broking's Piyush Pandey. Conversely, Nirmal Bang has issued the lowest target among approximately 30 brokerages, pegging the stock at Rs 1,578 and recommending a 'Sell' rating.

Many analysts found TCS's Q2 numbers to be soft, particularly concerning underlying growth and order-book momentum. Margin pressures also continued to be a recurring theme in their assessments.

Brokerage Insights and Ratings

  • Morgan Stanley: Gaurav Rateria suggested 'Equal weight' with a target of Rs 2,160.
  • CLSA: Sumeet Jain recommended 'Hold' with a target of Rs 2,038.
  • UBS: Aditya Chandrasekar assigned a 'Neutral' rating and a target of Rs 2,565.
  • JPMorgan: Provided a target of Rs 2,300.
  • Jefferies & Citi: Issued lower targets of Rs 1,800 and Rs 1,840, respectively.

Key Concerns and Growth Drivers

Nomura retained its 'Buy' rating with an unchanged target of Rs 2,630, acknowledging that investments are likely to weigh on margins in FY27. However, Nomura noted no fundamental change in the demand environment for TCS, with continued scrutiny on discretionary spending that offers no immediate benefits.

Nirmal Bang Institutional Equities highlighted that TCS's deal wins, at $9.6 billion, remained soft and did not indicate a meaningful acceleration in demand. They pointed to Q2FY27 constant currency growth of just 0.5% quarter-on-quarter and TCV (Total Contract Value) down 4% year-on-year. Management indicated a selective demand environment, with discretionary programs lacking near-term value still under scrutiny.

MOFSL also observed no significant change in demand commentary, with measured decision-making on discretionary programs. While TCV increased and client conversations remained constructive, the near-term outlook is seen as dependent on pipeline conversion and a recovery in regional markets, with a target of Rs 2,400.

Positive Outlooks Amidst Challenges

Despite the challenges, Nuvama maintained a positive stance, reiterating a 'BUY' rating with an unchanged target of Rs 2,750. They believe TCS is well-positioned for a gradual recovery in FY27, driven by improving international growth and strong traction in AI revenue, which now constitutes 10% of total revenues. Nuvama views current investments for growth as a sound strategy, even if they pressure near-term margins.

Antique Stock Broking described TCS's Q2 as a mixed bag. Growth was observed in BFSI, Manufacturing, and Technology sectors, broadening across international markets. However, a project deferral in India impacted overall performance and moderated deal momentum. Antique suggested a 'Hold' with a target of Rs 2,325.

JM Financial noted that near-term growth could benefit from a seasonal recovery in consumer business and the BSNL ramp-up, though Q3 furloughs are expected to be a similar headwind to last year. They maintained an 'ADD' rating with an unchanged target of Rs 2,375.

Other Notable Brokerage Targets:

  • HSBC: Rs 2,350
  • BNP Paribas: Rs 2,400
  • Anand Rathi: Rs 2,430
  • ICICI Securities: Rs 1,920
  • Axis Capital: Rs 2,550
  • IIFL: Rs 2,500

The varied analyst targets reflect the complex operational landscape for TCS, balancing ongoing investments in growth areas like AI with persistent scrutiny on discretionary spending and margin management.

Related